Methotrexate- and/or cytarabine-based chemotherapy may be effective and safe in solid-organ transplant recipients with primary central nervous system lymphomas. [electronic resource]
Producer: 20110621Description: 521-4 p. digitalISSN:- 1029-2403
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Central Nervous System Neoplasms -- drug therapy
- Cytarabine -- administration & dosage
- Dose-Response Relationship, Drug
- Feasibility Studies
- Follow-Up Studies
- Humans
- Immunosuppression Therapy -- adverse effects
- Lymphoma -- drug therapy
- Methotrexate -- administration & dosage
- Middle Aged
- Organ Transplantation -- methods
- Recurrence
- Remission Induction
- Transplantation
- Treatment Outcome
No physical items for this record
Publication Type: Controlled Clinical Trial; Letter
There are no comments on this title.
Log in to your account to post a comment.